• Exchange: ASE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Audeo Oncology Inc

0602211D:AU

Pending Listing

Audeo Oncology Inc (0602211D:AU) is pending listing


Company Profile

Audeo Oncology, Inc. is a late stage biopharmaceutical company primarily focused on utilizing Hyaluronic Acid Chemotransport Technology, or HyACT, to target cancer drugs preferentially to tumor cells to enhance drug activity.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...
Advertisement
sec ||= nil